AMPK Activation Reduces Heart Cell Death During Injury
Author Information
Author(s): Yeh Chi-Hsiao, Chen Tzu-Ping, Wang Yao-Chang, Lin Yu-Min, Fang Shu-Wen
Primary Institution: Chang Gung Memorial Hospital
Hypothesis
Can AMPK activation attenuate cardiomyocytic apoptosis after cardioplegia-induced hypoxia/reoxygenation injury?
Conclusion
AMPK activation during cardioplegia-induced H/R injury reduces heart cell death by enhancing protective responses and reducing stress.
Supporting Evidence
- AMPK activation reduced the percentage of apoptotic cardiomyocytes after injury.
- Antiapoptotic proteins were elevated with AMPK activation.
- Proapoptotic proteins were reduced with AMPK activation.
- AMPK activation may serve as a future pharmacological target to reduce heart injury.
Takeaway
This study shows that a special protein called AMPK can help heart cells survive better when they are injured by lack of oxygen.
Methodology
Cardiomyocytes were exposed to simulated ischemia and treated with AMPK activators before reoxygenation, followed by analysis of apoptosis markers.
Limitations
The study used HL-1 cardiomyocytes instead of primary cardiomyocytes.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website